William Aird: Was Hematology–Oncology an Inevitable Partnership?
William Aird, Professor of Medicine at Harvard Medical School, shared a post on LinkedIn:
“A Match Made In… History?
Why hematology-oncology?
Why not urology-oncology?
Or GI-oncology?
It sounds like a joke. Maybe it shouldn’t.
In the U.S., hematology and oncology are treated as a natural pair. But the pairing was never written into biology.
If patient overlap alone determined specialty marriages, the map would look different.
Urologic cancers: more than half a million new U.S. diagnoses a year.
GI cancers: roughly 370,000.
Breast cancer: over 300,000.
Leukemia, lymphoma, and myeloma combined: about 190,000.
So patient volume cannot be the whole answer.
The answer lies, at least in part, in history — especially in the United States:
The contested borderland of leukemia, lymphoma, chemotherapy, marrow failure, transfusion, and bone marrow transplantation, which gradually became shared clinics, shared treatments, shared training, shared boards, and shared identity.
And yet the two fields still feel different.
Hematology leans diagnostic: What is the pattern? What is the mechanism — inherited, immune, nutritional, reactive, clonal, marrow-based, peripheral?
Oncology leans therapeutic: What is the stage? The target? The regimen? The sequence? The trial?
An oversimplification, of course. Hematologists treat. Oncologists diagnose. Blood cancers belong fully to both.
But specialties are not natural laws. They are historical settlements — useful, sometimes elegant, sometimes awkward.
If we organized medicine today from first principles rather than inherited precedent, would we still pair hematology with oncology?”
Other posts featuring William Aird on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support